연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
3051. Incidence of bactibilia and related factors in patients who undergo cholecystectomy.
Moon DK, Kang JS, Byun Y, Choi YJ, Lee HW, Jang JY, Lim CS.
Ann Surg Treat Res. 2023 Jan;104(1):10-17.
Link
3050. Development of Spleen Targeting H2S Donor Loaded Liposome for the Effective Systemic Immunomodulation and Treatment of Inflammatory Bowel Disease
Chiwoo Oh 1, Wooseung Lee 1, Jeongbin Park 2, Jinyeong Choi 1, Somin Lee 2, Shengjun Li 2, Han Na Jung 1, Jeong-Seob Lee 1, Jee-Eun Hwang 2, Jiwoo Park 2, MinKyu Kim 1, Seungki Baek 1, Hyung-Jun Im 1 2 3 4
ACS Nano
. 2023 Mar 14;17(5):4327-4345.
Link
3049. In vitro magnetic hyperthermia properties of angle-shaped superparamagnetic iron oxide nanoparticles synthesized by a bromide-assisted polyol method
Hoonsub Kim 1, Pyung Won Im 2, Chaedong Lee 1, Hwichan Hong 1, Wooseung Lee 1, Changhyuk Koo 1, Sang Yoon Park 3, Hyung-Jun Im 1 2 4, Sun Ha Paek 2 4 5, Yuanzhe Piao 1 3
RSC Adv
. 2023 Jan 19;13(5):2803-2810.
Link
3048. 18F-FDG PET/CT in the Management of Osteosarcoma
Chiwoo Oh 1, Michael W Bishop 2, Steve Y Cho 3, Hyung-Jun Im 4 5 6, Barry L Shulkin 7
J Nucl Med
. 2023 Jun;64(6):842-851.
Link
3047. Injectable biocompatible nanocomposites of Prussian blue nanoparticles and bacterial cellulose as a safe and effective photothermal cancer therapy
Hwichan Hong # 1, MinKyu Kim # 1, Wooseung Lee 1, Miyeon Jeon 1, Chaedong Lee 1, Hoonsub Kim 1, Hyung-Jun Im 2 3 4 5 6, Yuanzhe Piao 7 8 9
J Nanobiotechnology
. 2023 Oct 5;21(1):365.
Link
3046. HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results
Jeongmin Seo,, Jiwon Koh, Dae-Won Lee, Jinyong Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im
Breast Cancer Res 2023 Dec 14;25(1):154.
Link
3045. The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
Choi JE, Lee JS, Jin MS, Nikas IP, Kim K, Yang S, Park SY, Koh J, Yang S, Im SA, Ryu HS.
Breast Cancer Res 2023 Nov 3;25(1):134
Link
3044. Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Kim SH, Im SA, Suh KJ, Lee KH, Kim MH, Sohn J, Park YH, Kim JY, Jeong JH, Lee KE, Choi IS, Park KH, Kim HJ, Cho EK, Park SY, Kim M, Kim JH.
Eur J Cancer 2023 Dec:195:113386.
Link
3043. Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Eunice Yoojin Lee, Dae-Won Lee, Kyung-Hun Lee,
Seock-Ah Im
Cancer Res Treat 2023 Oct;55(4):1065-1076.
Link
3042. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
S.-A. Im, A. Gennari, Y. H. Park, J. H. Kim, Z.-F. Jiang, S. Gupta, T. H. Fadjari, K. Tamura, M. Y. Mastura, M. L. T. Abesamis-Tiambeng, E. H. Lim, C.-H. Lin, A. Sookprasert, N. Parinyanitikul, L.-M. Tseng, S.-C. Lee, P. Caguioa, M. Singh, Y. Naito, R. A. Hukom, B. K. Smruti, S.-S. Wang, S. B. Kim, K.-H. Lee, H. K. Ahn, S. Peters, T. W. Kim, T. Yoshino, G. Pentheroudakis, G. Curigliano, N. Harbeck
ESMO Open 2023 Jun;8(3):101541.
Link